PP
NEO icon

Paloma Partners’s NeoGenomics NEO Stock Holding History

Paloma Partners’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-17,306
Closed -$255K – 818
2024
Q3 		$255K Buy
+17,306
New +$271K 0.01% 882
2022
Q1 		– Sell
-6,355
Closed -$217K – 2088
2021
Q4 		$217K Buy
+6,355
New +$249K ﹤0.01% 1562
2020
Q3 		– Sell
-7,950
Closed -$246K – 2328
2020
Q2 		$246K Buy
+7,950
New +$220K ﹤0.01% 1580
2019
Q1 		– Sell
-13,622
Closed -$172K – 1847
2018
Q4 		$172K Buy
+13,622
New +$203K 0.01% 1076
2014
Q3 		– Sell
-140,491
Closed -$466K – 1207
2014
Q2 		$466K Buy
+140,491
New +$467K 0.02% 613

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Paloma Partners's NEO Position: Q4 2024 in Review

Paloma Partners sold out of NeoGenomics (NEO) in Q4 2024, closing a stake of 17,306 shares — an estimated $255K sold.

Paloma Partners first reported a position in NEO in Q2 2014 and held it in 5 quarters. The position peaked at $466K in Q2 2014. 253 funds tracked by Wall St. Rank hold NEO as of Q4 2024.

  • Paloma Partners reported no remaining NeoGenomics position as of Q4 2024 after selling out during the quarter.
  • Paloma Partners sold 17,306 NeoGenomics shares in Q4 2024, an estimated $255K.
  • Paloma Partners first reported a position in NeoGenomics in Q2 2014 and held it in 5 quarters.
  • Paloma Partners's NeoGenomics position peaked at $466K in Q2 2014.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.